Caption Management, LLC Reata Pharmaceuticals Inc Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $1.09 Million - $2.04 Million	56,010 New	56,010 $1.41 Million
Q4 2021 Feb 11, 2022	BUY	$25.61 - $110.96 $2.56 Million - $11.1 Million	99,900 New	99,900 $2.63 Million
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $352,215 - $680,805	-4,500 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$94.25 - $132.81 $3.26 Million - $4.6 Million	-34,600 Reduced 88.49%	4,500 $450,000
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $3.31 Million - $4.63 Million	26,200 Added 203.1%	39,100 $6.1 Million
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $2.8 Million - $5.58 Million	-22,516 Reduced 63.58%	12,900 $1.86 Million
Q4 2019 Feb 13, 2020	BUY	$74.57 - $217.92 $2.64 Million - $7.72 Million	35,416 New	35,416 $7.24 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.